Craig Wang
Craig Wang
Biostatistician at Novartis
Verified email at
Cited by
Cited by
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III …
DJ Slamon, P Neven, S Chia, G Jerusalem, M De Laurentiis, S Im, ...
Annals of oncology 32 (8), 1015-1024, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2 Advanced …
YS Lu, SA Im, M Colleoni, F Franke, A Bardia, F Cardoso, N Harbeck, ...
Clinical Cancer Research 28 (5), 851-859, 2022
Modelling anthelmintic resistance by extending eggCounts package to allow individual efficacy
C Wang, PR Torgerson, RM Kaplan, MM George, R Furrer
International Journal for Parasitology: Drugs and Drug Resistance 8 (3), 386-393, 2018
Updated overall survival (OS) results from the phase III MONALEESA-3 trial of postmenopausal patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with fulvestrant …
DJ Slamon, P Neven, SKL Chia, GHM Jerusalem, M De Laurentiis, SA Im, ...
J Clin Oncol 39 (15_suppl), 1001-1001, 2021
Epidemic cystic and alveolar echinococcosis in Kyrgyzstan: an analysis of national surveillance data
G Paternoster, G Boo, C Wang, G Minbaeva, J Usubalieva, KM Raimkulov, ...
The Lancet Global Health 8 (4), e603-e611, 2020
Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre-or perimenopausal patients with hormone receptor positive/human epidermal …
D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, S Hurvitz, ...
Cancer Research 81 (4_Supplement), PD2-04-PD2-04, 2021
Zero-inflated hierarchical models for faecal egg counts to assess anthelmintic efficacy
C Wang, PR Torgerson, J Höglund, R Furrer
Veterinary parasitology 235, 20-28, 2017
Generalized spatial fusion model framework for joint analysis of point and areal data
C Wang, MA Puhan, R Furrer, SNC Study Group
Spatial Statistics 23, 72-90, 2018
LBA4 Updated overall survival (OS) results from the first-line (1L) population in the phase III MONALEESA-3 trial of postmenopausal patients (PTS) with HR+/HER2− advanced …
P Neven, PA Fasching, S Chia, G Jerusalem, M De Laurentiis, SA Im, ...
Annals of Oncology 33, S194, 2022
Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis
B Holzhauer, C Wang, H Schmidli
Statistics in medicine 37 (6), 867-882, 2018
Local-likelihood transformation Kernel Density Estimation for positive random variables
G Geenens, C Wang
Journal of Computational and Graphical Statistics 27 (4), 822-835, 2018
eggCounts: Hierarchical Modelling of Faecal Egg Counts
C Wang, M Paul, R Furrer
R package version 2.0, 2018
Call completion probability in heterogeneous networks with energy harvesting base stations
C Wang, S Durrani, J Guo, X Zhou
2015 22nd International Conference on Telecommunications (ICT), 191-197, 2015
Combining heterogeneous spatial datasets with process-based spatial fusion models: A unifying framework
C Wang, R Furrer, SNC Study Group
Computational Statistics & Data Analysis 161, 107240, 2021
Increase in airway obstruction between 1993 and 2012 in Switzerland. An observational study
EA West, A Strassmann, C Wang, A Turk, K de Hoogh, M Röösli, M Bopp, ...
Annals of the American Thoracic Society 17 (4), 457-465, 2020
Sensitivity analyses for the principal ignorability assumption using multiple imputation
C Wang, Y Zhang, F Mealli, B Bornkamp
Pharmaceutical Statistics, 2022
eggCounts: a Bayesian hierarchical toolkit to model faecal egg count reductions
C Wang, R Furrer
arXiv preprint arXiv:1804.11224, 2018
Methodology for Good Machine Learning with Multi‐Omics Data
T Coroller, B Sahiner, A Amatya, A Gossmann, K Karagiannis, C Moloney, ...
Clinical Pharmacology & Therapeutics 115 (4), 745-757, 2024
Efficient inference of generalized spatial fusion models with flexible specification
C Wang, R Furrer
Stat 8 (1), e216, 2019
Multi-omics investigation on the prognostic and predictive factors in metastatic breast cancer using data from Phase III ribociclib clinical trials: A statistical and machine …
TP Coroller, B Sahiner, A Amatya, A Gossman, K Karagiannis, RK Samala, ...
medRxiv, 2023.08. 30.23294367, 2023
The system can't perform the operation now. Try again later.
Articles 1–20